普洛药业累计回购1006万股 耗资1.44亿元
Core Viewpoint - The company, Prologis Pharmaceutical, has announced a share buyback program, indicating a strategic move to enhance shareholder value through the repurchase of its own shares [1] Summary by Categories Share Buyback - The company has repurchased a total of 10.06 million shares, which represents 0.87% of its current total share capital [1] - The total amount spent on the share buyback is 144 million yuan, excluding transaction fees [1]